Psychometric properties of a patient-reported outcome set in acute stroke patients.


Journal

Brain and behavior
ISSN: 2162-3279
Titre abrégé: Brain Behav
Pays: United States
ID NLM: 101570837

Informations de publication

Date de publication:
08 2021
Historique:
revised: 25 05 2021
received: 25 08 2020
accepted: 27 05 2021
pubmed: 15 6 2021
medline: 23 9 2021
entrez: 14 6 2021
Statut: ppublish

Résumé

Impairments after stroke may affect multiple domains of health-related quality of life (HRQoL). Patient-reported outcome measures (PROMs) have proven valuable in measuring patients' well-being. We examine the psychometric properties of a standard set of PROMs assessing global health, anxiety, and depression, and functioning in a German health care setting. We included inpatients at the Department of Neurology at the University Medical Center Hamburg-Eppendorf, diagnosed with stroke. Following the stroke-specific standard set of the International Consortium for Health Outcome Measurement, we collected demographic and clinical information at baseline, and PROMs for global health (PROMIS-10), three items for self-reported functioning, anxiety, and depression (PHQ-4) at 90 days follow-up. We calculated confirmatory factor analyses to test factorial validity and correlation analyses to test construct validity. We further conducted item and reliability analyses. In a sample of 487 patients (mean age, SD: 71.1, 12.6; 47% female) with mild and moderate symptoms, model fit for the PROMIS-10 was acceptable for the two-factor and single-factor models. Factor loadings ranged from 0.52 to 0.94. The postulated single-factor model for functioning was saturated with zero degrees of freedom. Factor loadings ranged from 0.90 to 0.96. For the PHQ-4, the two-factor model showed excellent model fit. Factor loadings ranged from 0.78 to 0.87. Internal consistency was acceptable to good. Construct validity was generally confirmed. The PROMIS-10 is a valid and reliable instrument to measure HRQoL among German stroke patients. While the PHQ-4 was confirmed as a screening measure for mental disorders, further research is needed on items assessing self-reported functioning. Results are limited to patients showing minimal functional deficits.

Identifiants

pubmed: 34124861
doi: 10.1002/brb3.2249
pmc: PMC8413767
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2249

Informations de copyright

© 2021 The Authors. Brain and Behavior published by Wiley Periodicals LLC.

Références

J Am Heart Assoc. 2017 Jul 21;6(7):
pubmed: 28733434
JAMA. 1995 Jan 4;273(1):59-65
pubmed: 7996652
Health Qual Life Outcomes. 2016 Nov 24;14(1):161
pubmed: 27881127
J Clin Epidemiol. 2010 Nov;63(11):1179-94
pubmed: 20685078
Brain Behav. 2021 Aug;11(8):e2249
pubmed: 34124861
Br J Psychiatry. 2013 Jan;202(1):14-21
pubmed: 23284148
J Eval Clin Pract. 2006 Oct;12(5):559-68
pubmed: 16987118
Stroke. 2014 Jun;45(6):1784-90
pubmed: 24803595
Qual Life Res. 2019 May;28(5):1119-1128
pubmed: 30465318
J Am Heart Assoc. 2019 Jun 4;8(11):e012421
pubmed: 31131666
Phys Med Rehabil Clin N Am. 2015 Nov;26(4):583-98
pubmed: 26522899
Qual Life Res. 2009 Sep;18(7):873-80
pubmed: 19543809
Int J Stroke. 2014 Dec;9(8):1017-25
pubmed: 25117911
Neurology. 2018 Apr 17;90(16):717-718
pubmed: 29592887
Control Clin Trials. 2004 Dec;25(6):535-52
pubmed: 15588741
Qual Life Res. 2008 Nov;17(9):1125-35
pubmed: 18836850
J Rehabil Med. 2018 Sep 28;50(9):769-778
pubmed: 30184240
J Clin Epidemiol. 2014 May;67(5):516-26
pubmed: 24698295
Neurol Res Pract. 2019 Nov 1;1:28
pubmed: 33324894
Psychosomatics. 2009 Nov-Dec;50(6):613-21
pubmed: 19996233
Stroke. 2018 Jan;49(1):147-154
pubmed: 29273595
Stroke. 1994 Nov;25(11):2220-6
pubmed: 7974549
Adv Ther. 2017 Feb;34(2):452-465
pubmed: 28000165
Health Aff (Millwood). 2012 Mar;31(3):497-504
pubmed: 22392660
Neurology. 2018 Dec 4;91(23):e2182-e2191
pubmed: 30381370
N Engl J Med. 2017 Jul 6;377(1):6-9
pubmed: 28679102
J Sex Med. 2008 Jan;5(1):92-9
pubmed: 17466059
Psychol Med. 2002 Nov;32(8):1345-56
pubmed: 12455933
NeuroRehabilitation. 2014;35(1):1-7
pubmed: 24990001
Soc Sci Med. 2005 Feb;60(4):833-43
pubmed: 15571900
Continuum (Minneap Minn). 2017 Feb;23(1, Cerebrovascular Disease):238-253
pubmed: 28157752
Educ Psychol Meas. 2019 Apr;79(2):310-334
pubmed: 30911195
Disabil Rehabil. 2005 Feb 18;27(4):170-5
pubmed: 15824047
Qual Life Res. 2019 Mar;28(3):567-592
pubmed: 30284183
J Affect Disord. 2010 Apr;122(1-2):86-95
pubmed: 19616305
Stroke. 1988 May;19(5):604-7
pubmed: 3363593
Med Care. 2013 Aug;51(8 Suppl 3):S73-9
pubmed: 23774513
Clin Rehabil. 2013 Aug;27(8):724-7
pubmed: 23411790
Stroke. 2018 Jun;49(6):1549-1556
pubmed: 29789396
J Clin Oncol. 2014 May 10;32(14):1480-501
pubmed: 24711559
Gen Hosp Psychiatry. 2017 Jul;47:48-60
pubmed: 28807138
Neurology. 2018 Apr 17;90(16):e1364-e1371
pubmed: 29592886
Neurorehabil Neural Repair. 2007 Mar-Apr;21(2):161-8
pubmed: 17312091
Stroke. 2016 Jan;47(1):180-6
pubmed: 26604251
Neurology. 2003 Jan 28;60(2):291-6
pubmed: 12552047
Psychol Bull. 1992 Jul;112(1):155-9
pubmed: 19565683

Auteurs

Rebecca Philipp (R)

Department of Medical Psychology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Lisa Lebherz (L)

Department of Medical Psychology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Götz Thomalla (G)

Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Martin Härter (M)

Department of Medical Psychology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Hannes Appelbohm (H)

Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Marc Frese (M)

Office for Quality Management and Clinical Process Management, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Levente Kriston (L)

Department of Medical Psychology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH